Mental Disorder Treatment Market, by Disorder Type (Depression, Bipolar Disorder, Schizophrenia, Dementia, Post-traumatic Stress Disorder, and Others), by Medication (Anti-depressants, Anti-anxiety, Mood Stabilizing Medication, and Antipsychotic Medicati

Mental Disorder Treatment Market, by Disorder Type (Depression, Bipolar Disorder, Schizophrenia, Dementia, Post-traumatic Stress Disorder, and Others), by Medication (Anti-depressants, Anti-anxiety, Mood Stabilizing Medication, and Antipsychotic Medications), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

The mental disorder include various different types of mental disorders such as depression, bipolar disorder, schizophrenia, dementia, post traumatic disorders, and others. These mental disorders are treated with the help of medications or psycho-therapies. Moreover, various medications used for the treatment of these mental disorders include anti-depressants, anti-anxiety medications, anti-psychotic medications, and mood stabilizing medication.
Market Dynamics
Key companies are focusing on product launches for the treatment of mental disorders such as depression, bipolar disorders to strengthen their position in the global mental disorder treatment market. For instance, in 2017, Lupin Limited, launched its anti-depressant, Bupropion Hydrochloride extended release tablets, indicated for the treatment of major depressive disorder, in the U.S. market.
Key features of the study:
This report studies the current scenario as well as the future potential of the global mental disorder treatment market. The market for is segmented on basis of disorder type, medication, distribution channel, and region.
This report provides in-depth analysis of the global mental disorder treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR) (%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by leading players.
It profiles leading players in the global mental disorder treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
The global mental disorder treatment market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global mental disorder treatment market
Detailed Segmentation:
Global Mental Disorder Treatment Market, By Disorder Type:
Depression
Bipolar Disorder
Schizophrenia
Dementia
Post-traumatic Stress Disorder
Others
Global Mental Disorder Treatment Market, By Medication:
Anti-depressants
Anti-anxiety
Mood Stabilizing Medication
Antipsychotic Medications
Global Mental Disorder Treatment Market, By Distribution Channel :
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Mental Disorder Treatment Market, By Region:
North America
By Disorder Type:
Depression
Bipolar Disorder
Schizophrenia
Dementia
Post-traumatic Stress Disorder
Others
By Medication:
Anti-depressants
Anti-anxiety
Mood Stabilizing Medication
Antipsychotic Medications
By Distribution Channel :
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Latin America
By Disorder Type:
Depression
Bipolar Disorder
Schizophrenia
Dementia
Post-traumatic Stress Disorder
Others
By Medication:
Anti-depressants
Anti-anxiety
Mood Stabilizing Medication
Antipsychotic Medications
By Distribution Channel :
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Disorder Type:
Depression
Bipolar Disorder
Schizophrenia
Dementia
Post-traumatic Stress Disorder
Others
By Medication:
Anti-depressants
Anti-anxiety
Mood Stabilizing Medication
Antipsychotic Medications
By Distribution Channel :
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Disorder Type:
Depression
Bipolar Disorder
Schizophrenia
Dementia
Post-traumatic Stress Disorder
Others
By Medication:
Anti-depressants
Anti-anxiety
Mood Stabilizing Medication
Antipsychotic Medications
By Distribution Channel :
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Disorder Type:
Depression
Bipolar Disorder
Schizophrenia
Dementia
Post-traumatic Stress Disorder
Others
By Medication:
Anti-depressants
Anti-anxiety
Mood Stabilizing Medication
Antipsychotic Medications
By Distribution Channel :
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
GCC
Israel
Rest of Middle East
Africa
By Disorder Type:
Depression
Bipolar Disorder
Schizophrenia
Dementia
Post-traumatic Stress Disorder
Others
By Medication:
Anti-depressants
Anti-anxiety
Mood Stabilizing Medication
Antipsychotic Medications
By Distribution Channel :
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Allergan plc.*
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
Eli Lilly and Company
VistaGen Therapeutics
Sanofi S.A
Novartis International AG
Mylan N.V.
Amneal Pharmaceuticals LLC
Cipla Ltd
Sun Pharmaceutical Industries Ltd.
Glenmark Pharmaceuticals Limited
Lupin Limited
Janssen Pharmaceutica
Bristol Myers Squibb
Sumitomo Dainippon Pharma Co., Ltd
“*” marked represents similar segmentation in other categories in the respective section